Clinical Trial Update: Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months [NA]

View source ↗

Summary

This entry reports a completed clinical trial studying methods to reduce cardiovascular disease risk over 12 months in people living with HIV on antiretroviral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Snippet

Sponsor: Holdsworth House Medical Practice | Conditions: HIV-1 Infection, Cardiovascular Disease | NA | Status: COMPLETED